The World Health Organization (WHO) admitted on Saturday that everyone who receives the Monkeypox jab will be part of a massive “clinical study” for the purposes of establishing the safety of the newly developed experimental vaccine.
On Saturday, WHO conducted a press conference led by WHO Director-General Tedros Adhanom Ghebreyesus to warn the world of the Monkeypox outbreak.
Tim Nguyen, the Unit Head of Global Infectious Hazards Preparedness at the World Health Organization Emergency Programme, said that the vaccine efficacy is not yet known since it has never been used on this scale before.
“I would like to underline one thing that is very important to WHO. We do have uncertainty around the effectiveness of these vaccines because they haven’t been used in this context and in this scale before,” Tim Nguyen warned.
Thegatewaypundit.com reports: Nguyen warned that anyone who received the Monkeypox vaccination is technically participating in a “clinical trial” to determine the vaccine’s efficacy.
“And therefore, when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting this data to increase our understanding of the effectiveness of these vaccines,” he said.
According to CDC, there are only two vaccines licensed by the U.S. Food and Drug Administration (FDA) available for “preventing monkeypox infection” – JYNNEOS (also known as Imvamune or Imvanex) and ACAM2000.
On the same day, the World Health Organization (WHO) declared the monkeypox outbreak a global health emergency on Saturday just before the midterm election.
According to reports, Tedros overruled the decision of 8 members of the expert committee who voted against the declaration, only 6 are in favor.